Skip to Main Content

Paper Details

[Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?]
Aktuelle Urol
0
2024
Alter, Olaparib, Patienten, Patients, Prostatakarzinoms, Taxanen, Tumorerkrankung, geriatric, mCRPC, mHSPC, olaparib, patient, patients, prostate cancer, taxanes, tumour disease
Author NameAffiliation
Bernd WullichUniversitatsklinikum Erlangen
Bernd WullichComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN)
Bernd WullichUniversitatsklinikum Erlangen
Bernd WullichComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN)
  • 1 - 4

Datasets

Release 1.2